Application of long non-coding lncRNA-od1 in osteoporosis disease
A long-chain non-coding, osteoporosis technology, applied in the field of molecular biomedicine, to achieve the effect of high development value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030]Below in conjunction with accompanying drawing and operation method, the present invention is described in detail.
[0031] 1. Method
[0032] 1.1 Osteoporosis group: randomly selected 10 patients with primary osteoporosis admitted to the orthopedics department of the hospital, 5 males and 5 females, aged 65-75 years. The inclusion criteria met: the second draft of "Recommended Diagnostic Criteria for Osteoporosis in China". No other obvious heart, liver, lung and other diseases, no various diseases that cause secondary osteoporosis, and those who have bone metabolism caused by thyroid, tumor, diabetes and other serious diseases are excluded. Normal group: 10 healthy outpatient volunteers aged 65-75 were selected, 5 males and 5 females. There was no statistically significant difference in age and sex between the two groups (p>0.01), which were comparable. All research subjects gave informed consent.
[0033] 1.2 Blood RNA extraction: TRI pure LS Reagent is used for R...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com